Marianne Geiger
Psychiatry · Newport, ORNPI 1639215015
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,722 and has fallen 94.0% since, to $103 in 2023. Among psychiatry clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$562
- Otsuka America Pharmaceutical, Inc.$545
- Neurocrine Biosciences, Inc.$397
- Vanda Pharmaceuticals Inc.$340
- Lundbeck LLC$296
- Sunovion Pharmaceuticals Inc.$234
- plus $877 from 16 others
What the payments were for
- Food & beverage$3,251100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $562 |
| Otsuka America Pharmaceutical, Inc. | 23 | $545 |
| Neurocrine Biosciences, Inc. | 24 | $397 |
| Vanda Pharmaceuticals Inc. | 16 | $340 |
| Lundbeck LLC | 24 | $296 |
| Sunovion Pharmaceuticals Inc. | 14 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $220 |
| Biogen | 1 | $88 |
| OWP Pharmaceuticals, Inc. | 5 | $76 |
| Johnson & Johnson | 4 | $71 |
| Shire North American Group Inc | 4 | $70 |
| Alfasigma USA, Inc. | 3 | $69 |
| Ironshore Pharmaceuticals Inc. | 3 | $66 |
| Alkermes, Inc. | 2 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Tris Pharma Inc | 3 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Rhodes Pharmaceuticals L.p. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$209
- INGREZZA$118
- VRAYLAR$115
How this compares
$3,251 in reported general payments places this provider in the 95th percentile of 366 psychiatry providers in Oregon.
Other psychiatry in Newport
- Jean PointonNewport$441
- Andrew WilliamsBeaverton$84K
- Jacqueline AmatoMedford$27K
- Alisha MorelandPortland$20K
- Leigh Anne BresslerPortland$15K
- John LipkinEugene$15K
- Alfred LewyPortland$9K
- Hernan SchmidtEugene$8K
- Anca Maria BejenaruPortland$6K
- Erik VanderlipLake Oswego$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.